ResMed Inc. Common Stock (NY:RMD)

218.89 -2.26 (-1.02%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stocks That Hit 52-Week Lows On Friday ↗

September 15, 2023

Friday's session saw 169 companies set new 52-week lows.

Via Benzinga

3 Top Growth Stock Picks Trading at a Massive Bargain ↗

September 13, 2023

These growth stock picks are trading at bargain prices and are well-positioned to rebound and deliver substantial gains in the coming months.

Via InvestorPlace

Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks? ↗

September 07, 2023

The S&P 500 had a rare decline last month.

Via The Motley Fool

Topics Stocks

What 6 Analyst Ratings Have To Say About ResMed ↗

September 05, 2023

Via Benzinga

The Latest Analyst Ratings for ResMed ↗

August 14, 2023

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,000 Today ↗

August 10, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 07, 2023

On Thursday, 283 companies set new 52-week lows.

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

ResMed's Earnings: A Preview ↗

August 02, 2023

Via Benzinga

Here's How Much You Would Have Made Owning ResMed Stock In The Last 5 Years ↗

July 28, 2023

Via Benzinga

Sleep Device Player ResMed's Potential Obstacles: Analyst Weighs Obesity Drugs & Philips' Re-Entry ↗

September 06, 2023

Needham upgraded ResMed Inc (NYSE: RMD) from a Hold to Buy rating with a price target of $180

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗

September 06, 2023

Via Benzinga

ResMed Announces Participation in Upcoming Conferences

September 05, 2023

From ResMed Inc.

Via GlobeNewswire

Looking Into ResMed's Recent Short Interest ↗

July 26, 2023

Via Benzinga

Here's How Much $100 Invested In ResMed 20 Years Ago Would Be Worth Today ↗

July 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗

September 05, 2023

Via Benzinga

American Express To Rally Over 25%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

September 05, 2023

Wells Fargo raised the price target for Equity Residential (NYSE: EQR) from $62 to $69. Wells Fargo analyst James Feldman upgraded the stock from Equal-Weight to Overweight. Equity Residential shares...

Via Benzinga

3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy ↗

September 01, 2023

Mick Farrell might be kidding himself about the degree to which the popular weight-loss drugs will impact his company.

Via The Motley Fool

Late-Summer Steals: 7 Stocks to Buy Before Fall ↗

August 28, 2023

With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now.

Via InvestorPlace

3 Growth Stocks That Can Soar 50%, According to Wall Street ↗

August 25, 2023

Are these stocks the slam-dunk buys analysts think they are?

Via The Motley Fool

Stocks That Hit 52-Week Lows On Wednesday ↗

August 23, 2023

Wednesday's session saw 150 companies set new 52-week lows.

Via Benzinga

Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble ↗

August 21, 2023

With plenty of companies having their share prices corrected in August, it's time to shop for bargain stocks to buy on the dip.

Via InvestorPlace

5 Blue-Chip Stocks AI Thinks Will Double Your Money by 2027 ↗

August 16, 2023

Blue-chip stocks are traditionally market laggards, but the MarketMaster AI is flashing major "buy" signals in these 5 names right now.

Via InvestorPlace

Topics Artificial Intelligence

2 Stocks That Could Grow Your Portfolio Over the Next Decade ↗

August 15, 2023

These two promising stocks could help your portfolio grow steadily over the long term.

Via The Motley Fool

ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry ↗

August 04, 2023

ResMed Inc (NYSE: RMD) posted Q4 adjusted EPS of $1.60, up from $1.49 a year ago, missing the consensus of $1.67.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 04, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 04, 2023

On Friday, 73 companies reached new 52-week lows.

Via Benzinga

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023

August 03, 2023

From ResMed Inc.

Via GlobeNewswire

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023 ↗

August 01, 2023

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.